Researcher profile

Oleksii Proniakin

Oleksii Proniakin contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
2topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2025arXiv

MedPI: Evaluating AI Systems in Medical Patient-facing Interactions

We present MedPI, a high-dimensional benchmark for evaluating large language models (LLMs) in patient-clinician conversations. Unlike single-turn question-answer (QA) benchmarks, MedPI evaluates the medical dialogue across 105 dimensions comprising the medical process, treatment safety, treatment outcomes and doctor-patient communication across a granular, accreditation-aligned rubric. MedPI comprises five layers: (1) Patient Packets (synthetic EHR-like ground truth); (2) an AI Patient instantiated through an LLM with memory and affect; (3) a Task Matrix spanning encounter reasons (e.g. anxiety, pregnancy, wellness checkup) x encounter objectives (e.g. diagnosis, lifestyle advice, medication advice); (4) an Evaluation Framework with 105 dimensions on a 1-4 scale mapped to the Accreditation Council for Graduate Medical Education (ACGME) competencies; and (5) AI Judges that are calibrated, committee-based LLMs providing scores, flags, and evidence-linked rationales. We evaluate 9 flagship models -- Claude Opus 4.1, Claude Sonnet 4, MedGemma, Gemini 2.5 Pro, Llama 3.3 70b Instruct, GPT-5, GPT OSS 120b, o3, Grok-4 -- across 366 AI Patients and 7,097 conversations using a standardized "vanilla clinician" prompt. For all LLMs, we observe low performance across a variety of dimensions, in particular on differential diagnosis. Our work can help guide future use of LLMs for diagnosis and treatment recommendations.